We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

A Case of Recalcitrant DRESS Syndrome With Multiple Autoimmune Sequelae Treated With Intravenous Immunoglobulins

Elisha M. Singer, BA; Karolyn A. Wanat, MD; Misha A. Rosenbach, MD
JAMA Dermatol. 2013;149(4):494-495. doi:10.1001/jamadermatol.2013.1949.
Text Size: A A A
Published online


Correspondence: Dr Rosenbach, Department of Dermatology, Hospital of the University of Pennsylvania, 3600 Spruce St, 2 Maloney Bldg, Philadelphia, PA 19104 (Misha.Rosenbach@uphs.upenn.edu).

Conflict of Interest Disclosures: None reported.

This article was corrected for errors on May 1, 2013.

Kardaun SH, Sidoroff A, Valeyrie-Allanore L,  et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156(3):609-611
PubMed   |  Link to Article[[XSLOpenURL/10.1111/bjd.2007.156.issue-3]]
Brown RJ, Rother KI, Artman H,  et al. Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch Dermatol. 2009;145(1):63-66
PubMed   |  Link to Article[[XSLOpenURL/10.1001/archdermatol.2008.521]]
Cacoub P, Musette P, Descamps V,  et al. The DRESS syndrome: a literature review. Am J Med. 2011;124(7):588-597
PubMed   |  Link to Article[[XSLOpenURL/10.1016/j.amjmed.2011.01.017]]
Fields KS, Petersen MJ, Chiao E, Tristani-Firouzi P.Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG). J Drugs Dermatol. 2005;4(4):510-513
Joly P, Janela B, Tetart F,  et al. Poor benefit/risk balance of intravenous immunoglobulins in DRESS. Arch Dermatol. 2012;148(4):543-544
PubMed   |  Link to Article[[XSLOpenURL/10.1001/archderm.148.4.dlt120002-c]]
Hernandez-Bautista V, Yamazaki-Nakashimada MA, Vazquez-García R, Stamatelos-Albarrán D, Carrasco-Daza D, Rodríguez-Lozano AL.Treatment of Kimura disease with intravenous immunoglobulin. Pediatrics. 2011;128(6):e1633-e1635
PubMed   |  Link to Article[[XSLOpenURL/10.1542/peds.2010-1623]]
Orson FM.Intravenous immunoglobulin therapy suppresses manifestations of the angioedema with hypereosinophilia syndrome. Am J Med Sci. 2003;326(2):94-97
PubMed   |  Link to Article[[XSLOpenURL/10.1097/00000441-200308000-00007]]
Zhuang Q, Mazer B.Inhibition of IgE production in vitro by intact and fragmented intravenous immunoglobulin. J Allergy Clin Immunol. 2001;108(2):229-234
PubMed   |  Link to Article[[XSLOpenURL/10.1067/mai.2001.116291]]
Kano Y, Inaoka M, Sakuma K, Shiohara T.Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome. Toxicology. 2005;209(2):165-167
PubMed   |  Link to Article[[XSLOpenURL/10.1016/j.tox.2004.12.013]]
French LE, Trent JT, Kerdel FA.Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. Int Immunopharmacol. 2006;6(4):543-549
PubMed   |  Link to Article[[XSLOpenURL/10.1016/j.intimp.2005.11.012]]
Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption
Graphic Jump Location

Figure. Diffuse pink-to-red erythematous macules and papules with areas of coalescing patches involving the trunk and back (A) and bilateral upper and lower extremities (B).




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

4 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections